Interventional Cardiology Market Size, Share & COVID19 Impact Analysis | Global | 2023-2029 | MedSuite | Includes: Coronary Stent Market, Coronary Balloon Catheter Market and 10 more
- Year: 2023
- Scope: 10 Years
- Region: Global
- Pages: 577
- Type: MedSuite
Overall, the global interventional cardiology market was valued at $11 billion in 2022. This is expected to increase over the forecast period at a CAGR of 2.4% to reach $13 billion.
The full report suite on the global market for interventional cardiology includes the coronary stent, coronary balloon catheter, interventional coronary catheter, interventional coronary guidewire, coronary embolic protection device, atherectomy and intravascular lithotripsy (IVL) device, coronary introducer sheath, coronary vascular closure device (VCD), diagnostic catheter and guidewire, optical coherence tomography (OCT) catheter and intravascular ultrasound (IVUS) catheter markets.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Interventional Cardiology Procedure Volumes
- Market Forecasts Until 2029, and Historical Data to 2019
- Market Drivers & Limiters for Each Global Interventional Cardiology market
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact on the Global Interventional Cardiology market
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Interventional Cardiology Market Insights
Access to healthcare and overall hospital infrastructure in developing countries within Latin America and Asia-Pacific countries such as China and India have been increasing over the last decade. This has allowed for more of the global population to get interventional procedures completed as well as the expansion of the device market. Prices are expected to continue to decline over the forecast period, driven by the trend of consolidation in the market and bundling. Due to the number of competitors in the market, they often bundle together devices at a lower price in order to increase overall sales.
Adoption of intravascular imaging technologies is not yet equal across the globe. North America and Asia Pacific continue to have the highest usage rate of the devices, while the rest of the globe maintain a slow but growing use of the technology.
Global Interventional Cardiology Market Share Insight
In 2022, the global interventional cardiology market share was controlled by three key competitors – Boston Scientific, Abbott, and Medtronic.
Boston Scientific was the leader of several segments, including coronary stents, balloon catheters and embolic protection devices. Boston Scientific’s wide range of devices and complementary products for interventional cardiology, combined with its international sales team, has allowed it to maintain its dominant position
Abbott led the interventional coronary guidewire and OCT catheter markets in Western Europe. The Xience™ drug-eluting stent is a popular CTO-indicated line of coronary stents in terms of units sold.
Medtronic has a presence in the coronary stent, coronary balloon catheter, interventional coronary catheter, diagnostic catheter and guidewire, Interventional Coronary catheter, Guidewire Market, Embolic Protection Device Market and Coronary Introducer Sheath Market. Medtronic performed in the interventional coronary catheter market, where it offered the Launcher®, Sherpa NX™ Active, Sherpa NX™ Balanced and Telescope™ product lines under its portfolio.
Report Geographic Coverage
Throughout this research series, iData Research has covered several regions in great detail. The regions covered are:
- North America (United States and Canada)
- Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
- Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
- Central and Eastern Europe (Serbia, Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
- Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
- Africa( South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
Detailed Market Segmentation
While this MedSuite report contains all the Global Interventional Cardiology Devices market analysis and data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.
- Coronary Stent Market – MedCore
- Coronary Balloon Catheter Market – MedCore
- Interventional Coronary Catheter Market – MedCore
- Interventional Coronary Guidewire Market – MedCore
- Coronary Embolic Protection Device Market – MedCore
- Coronary Atherectomy & Intravascular Lithotripsy (IVL) Device Market – MedCore
- Coronary Introducer Sheath Market – MedCore
- Coronary Vascular Closure Device (VCD) Market – MedCore
- Diagnostic Coronary Catheter & Guidewire Market – MedCore
- Intravascular Ultrasound (IVUS) Market – MedCore
- Coronary Optical Coherency Tomography Catheter Market – MedCore
RESEARCH SCOPE SUMMARY
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
DON’T SEE THE SEGMENT OR DATA YOU NEED?
Feel free to contact us or send a request by pressing one of the buttons below.
The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite Table of Contents:
| TABLE of CONTENTS | |
| TABLE of CONTENTS | i |
| List of Figures | xii |
| List of Charts | xxviii |
| executive summary | 1 |
| Global Interventional Cardiology Device Market Overview | 1 |
| Competitive Analysis | 3 |
| Market Trends | 7 |
| Market Developments | 9 |
| Procedures Included | 11 |
| Markets Included | 12 |
| Regions Included | 13 |
| Version History | 15 |
| research methodology | 16 |
| Step 1: Project Initiation & Team Selection | 16 |
| Step 2: Prepare Data Systems and Perform Secondary Research | 19 |
| Step 3: Preparation for Interviews & Questionnaire Design | 21 |
| Step 4: Performing Primary Research | 22 |
| Step 5: Research Analysis: Establishing Baseline Estimates | 24 |
| Step 6: Market Forecast and Analysis | 25 |
| Step 7: Identify Strategic Opportunities | 27 |
| Step 8: Final Review and Market Release | 28 |
| Step 9: Customer Feedback and Market Monitoring | 29 |
| impact of covid-19 on THE global Interventional cardiology Market | 30 |
| 2.1 Introduction | 30 |
| 2.2 Regional Profiles | 32 |
| 2.3 Analysis By Market Segment | 34 |
| 2.3.1 Worst Case Scenario | 34 |
| 2.3.2 Base Case Scenario | 36 |
| 2.3.3 Best Case Scenario | 38 |
| Disease Overview | 41 |
| 3.1 Basic Anatomy | 41 |
| 3.2 Disease Treatment and Diagnostic | 43 |
| 3.2.1 General Diagnostics | 43 |
| 3.2.2 Coronary Artery Disease | 43 |
| 3.2.3 Myocardial Infarction | 44 |
| 3.2.4 Angina Pectoris | 45 |
| 3.3 Patient Demographics | 46 |
| Product Assessment | 48 |
| 4.1 Introduction | 48 |
| 4.2 Product Portfolios | 49 |
| 4.2.1 Coronary Stent Market | 49 |
| 4.2.2 Coronary Balloon Catheter Market | 51 |
| 4.2.3 Interventional Coronary Catheter Market | 53 |
| 4.2.4 Interventional Coronary Guidewire Market | 55 |
| 4.2.5 Coronary Embolic Protection Device Market | 57 |
| 4.2.5.1 Saphenous Vein Grafts | 57 |
| 4.2.5.2 Protection Mechanism | 57 |
| 4.2.5.2.1 Filter Basket | 57 |
| 4.2.5.2.2 Distal Balloon Occlusion | 58 |
| 4.2.6 Coronary Atherectomy and Intravascular Lithotripsy Device Market | 59 |
| 4.2.7 Introducer Sheath Market | 61 |
| 4.2.8 Coronary Vascular Closure Device Market | 64 |
| 4.2.9 Diagnostic Coronary Catheter & Guidewire Market | 66 |
| 4.2.10 Coronary Intravascular Ultrasound Market | 68 |
| 4.2.11 Coronary Optical Coherence Tomography Market | 70 |
| 4.3 Regulatory Issues and Recalls | 72 |
| 4.3.1 Coronary Stent Market FDA Recalls | 72 |
| 4.3.2 Coronary Balloon Catheter Market FDA Recalls | 74 |
| 4.3.3 Interventional Coronary Catheter Market FDA Recalls | 76 |
| 4.3.4 Interventional Coronary Guidewire Market FDA Recalls | 79 |
| 4.3.5 Coronary Atherectomy and Intravascular Lithotripsy Device Market FDA Recalls | 80 |
| 4.3.6 Coronary Introducer Sheath Market FDA Recalls | 81 |
| 4.3.7 Coronary Vascular Closure Device Market FDA Recalls | 85 |
| 4.3.8 Diagnostic Coronary Catheter & Guidewire Market FDA Recalls | 86 |
| 4.3.9 Coronary Intravascular Ultrasound Market FDA Recalls | 87 |
| 4.4 Clinical Trials | 88 |
| 4.4.1 Coronary Stent Market Clinical Trials | 89 |
| 4.4.2 Coronary Balloon Catheter Market Clinical Trials | 95 |
| 4.4.3 Interventional Coronary Catheter Market Clinical Trials | 99 |
| 4.4.4 Interventional Coronary Guidewire Market Clinical Trials | 101 |
| 4.4.5 Coronary Embolic Protection Device Market Clinical Trials | 102 |
| 4.4.6 Coronary Atherectomy and Intravascular Lithotripsy Device Market Clinical Trials | 104 |
| 4.4.7 Coronary Vascular Closure Device | 106 |
| 4.4.8 Coronary Intravascular Ultrasound | 112 |
| 4.4.9 Coronary Optical Coherence Tomography | 116 |
| Global Interventional cardiology Device Market Overview | 118 |
| 5.1 Introduction | 118 |
| 5.1.1 Population at Risk | 118 |
| 5.2 Market Overview & Trend Analysis | 120 |
| 5.2.1 By Segment | 120 |
| 5.2.2 By Region | 126 |
| 5.3 Drivers and Limiters | 130 |
| 5.3.1 Market Drivers | 130 |
| 5.3.2 Market Limiters | 132 |
| 5.4 Competitive Market Share Analysis | 134 |
| 5.5 Mergers and Acquisitions | 142 |
| 5.6 Company Profiles | 144 |
| 5.6.1 Abbott | 144 |
| 5.6.2 Asahi Intecc | 145 |
| 5.6.3 Boston Scientific | 146 |
| 5.6.4 Cook Medical | 147 |
| 5.6.5 Cordis | 148 |
| 5.6.6 Medtronic | 149 |
| 5.6.7 Penumbra | 150 |
| 5.6.8 Philips | 151 |
| 5.6.9 Teleflex | 152 |
| 5.6.10 Terumo | 153 |
| 5.7 SWOT Analysis | 154 |
| 5.7.1 Abbott | 155 |
| 5.7.2 Asahi Intecc | 157 |
| 5.7.3 Boston Scientific | 158 |
| 5.7.4 Cordis | 159 |
| 5.7.5 Cook Medical | 160 |
| 5.7.6 Medtronic | 161 |
| 5.7.7 Penumbra | 162 |
| 5.7.8 Philips | 163 |
| 5.7.9 Teleflex | 164 |
| 5.7.10 Terumo | 165 |
| Coronary Stent Market | 166 |
| 6.1 Executive Summary | 166 |
| 6.1.1 Global Coronary Stent Market Overview | 166 |
| 6.1.2 Competitive Analysis | 168 |
| 6.1.3 Procedures Included | 169 |
| 6.1.4 Markets Included | 170 |
| 6.1.5 Regions Included | 171 |
| 6.2 Introduction | 173 |
| 6.3 Procedure Numbers | 175 |
| 6.4 Market Overview | 189 |
| 6.4.1 By Segment | 190 |
| 6.4.2 By Region | 192 |
| 6.5 Market Analysis and Forecast | 194 |
| 6.5.1 Total Coronary Stent Market | 194 |
| 6.5.2 Bare-Metal Stent Market | 198 |
| 6.5.3 Drug-Eluting Stent Market | 202 |
| 6.6 Drivers and Limiters | 206 |
| 6.6.1 Market Drivers | 206 |
| 6.6.2 Market Limiters | 207 |
| 6.7 Competitive Market Share Analysis | 209 |
| Coronary Balloon Catheter Market | 213 |
| 7.1 Executive Summary | 213 |
| 7.1.1 Global Coronary Balloon Catheter Market Overview | 213 |
| 7.1.2 Competitive Analysis | 216 |
| 7.1.3 Procedures Included | 217 |
| 7.1.4 Markets Included | 218 |
| 7.1.5 Regions Included | 219 |
| 7.2 Introduction | 221 |
| 7.3 Procedure Numbers | 223 |
| 7.4 Market Overview | 237 |
| 7.4.1 By Segment | 238 |
| 7.4.2 By Region | 240 |
| 7.5 Market Analysis and Forecast | 242 |
| 7.5.1 Total Coronary Balloon Catheter Market | 242 |
| 7.5.2 PTCA Balloon Catheter Market | 246 |
| 7.5.3 Specialty Balloon Catheter Market | 250 |
| 7.6 Drivers and Limiters | 254 |
| 7.6.1 Market Drivers | 254 |
| 7.6.2 Market Limiters | 254 |
| 7.7 Competitive Market Share Analysis | 256 |
| interventional coronary catheter Market | 260 |
| 8.1 Executive Summary | 260 |
| 8.1.1 Global Interventional Coronary Catheter Market Overview | 260 |
| 8.1.2 Competitive Analysis | 262 |
| 8.1.3 Procedures Included | 263 |
| 8.1.4 Regions Included | 264 |
| 8.2 Introduction | 266 |
| 8.3 Procedure Numbers | 267 |
| 8.4 Market Analysis and Forecast | 281 |
| 8.5 Drivers and Limiters | 285 |
| 8.5.1 Market Drivers | 285 |
| 8.5.2 Market Limiters | 285 |
| 8.6 Competitive Market Share Analysis | 287 |
| Interventional Coronary guidewire Market | 291 |
| 9.1 Executive Summary | 291 |
| 9.1.1 Global Interventional Coronary Guidewire Market Overview | 291 |
| 9.1.2 Competitive Analysis | 293 |
| 9.1.3 Procedures Included | 294 |
| 9.1.4 Regions Included | 295 |
| 9.2 Introduction | 297 |
| 9.3 Procedure Numbers | 298 |
| 9.4 Market Analysis and Forecast | 312 |
| 9.5 Drivers and Limiters | 316 |
| 9.5.1 Market Drivers | 316 |
| 9.5.2 Market Limiters | 317 |
| 9.6 Competitive Market Share Analysis | 318 |
| Coronary embolic protection device Market | 322 |
| 10.1 Executive Summary | 322 |
| 10.1.1 Global Coronary Embolic Protection Device Market Overview | 322 |
| 10.1.2 Competitive Analysis | 325 |
| 10.1.3 Regions Included | 326 |
| 10.2 Introduction | 328 |
| 10.2.1 Protection Mechanism | 328 |
| 10.2.1.1 Filter Basket | 328 |
| 10.2.1.2 Distal Balloon Occlusion | 328 |
| 10.3 Market Analysis and Forecast | 330 |
| 10.4 Drivers and Limiters | 334 |
| 10.4.1 Market Drivers | 334 |
| 10.4.2 Market Limiters | 335 |
| 10.5 Competitive Market Share Analysis | 336 |
| Atherectomy and Intravascular Lithotripsy Device Market | 339 |
| 11.1 Executive Summary | 339 |
| 11.1.1 Global Atherectomy and Intravascular Lithotripsy Device Market Overview | 339 |
| 11.1.2 Competitive Analysis | 342 |
| 11.1.3 Procedures Included | 343 |
| 11.1.4 Regions Included | 344 |
| 11.2 Introduction | 346 |
| 11.3 Procedure Numbers | 347 |
| 11.4 Market Analysis and Forecast | 361 |
| 11.5 Drivers and Limiters | 365 |
| 11.5.1 Market Drivers | 365 |
| 11.5.2 Market Limiters | 366 |
| 11.6 Competitive Market Share Analysis | 367 |
| Coronary Introducer Sheath Market | 370 |
| 12.1 Executive Summary | 370 |
| 12.1.1 Global Coronary Introducer Sheath Market Overview | 370 |
| 12.1.2 Competitive Analysis | 373 |
| 12.1.3 Procedures Included | 374 |
| 12.1.4 Regions Included | 375 |
| 12.2 Introduction | 377 |
| 12.2.1 Introducer Sheaths | 377 |
| 12.2.2 Micro-Introducers | 377 |
| 12.2.3 Catheter Insertion Approaches | 378 |
| 12.2.3.1 Femoral Approach | 378 |
| 12.2.3.2 Radial/Brachial Approach | 378 |
| 12.3 Procedure Numbers | 379 |
| 12.4 Market Analysis and Forecast | 393 |
| 12.5 Drivers and Limiters | 397 |
| 12.5.1 Market Drivers | 397 |
| 12.5.2 Market Limiters | 397 |
| 12.6 Competitive Market Share Analysis | 399 |
| Coronary Vascular Closure Device Market | 404 |
| 13.1 Executive Summary | 404 |
| 13.1.1 Global Coronary Vascular Closure Device Market Overview | 404 |
| 13.1.2 Competitive Analysis | 406 |
| 13.1.3 Procedures Included | 407 |
| 13.1.4 Markets Included | 408 |
| 13.1.5 Regions Included | 409 |
| 13.2 Introduction | 411 |
| 13.2.1 Intravascular and Extravascular Devices | 411 |
| 13.3 Procedure Numbers | 412 |
| 13.4 Market Overview | 426 |
| 13.4.1 By Segment | 427 |
| 13.4.2 By Region | 429 |
| 13.5 Market Analysis and Forecast | 431 |
| 13.5.1 Total Coronary Vascular Closure Device Market | 431 |
| 13.5.2 Invasive VCD Market | 436 |
| 13.5.3 Non-Invasive VCD Market | 440 |
| 13.6 Drivers and Limiters | 444 |
| 13.6.1 Market Drivers | 444 |
| 13.6.2 Market Limiters | 445 |
| 13.7 Competitive Market Share Analysis | 446 |
| Diagnostic Catheter and Guidewire Market | 450 |
| 14.1 Executive Summary | 450 |
| 14.1.1 Global Diagnostic Catheter and Guidewire Market Overview | 450 |
| 14.1.2 Competitive Analysis | 453 |
| 14.1.3 Procedures Included | 454 |
| 14.1.4 Markets Included | 455 |
| 14.1.5 Regions Included | 456 |
| 14.2 Introduction | 458 |
| 14.3 Procedure Numbers | 459 |
| 14.3.1 Total Procedures | 459 |
| 14.3.2 Angiography Procedures | 460 |
| 14.3.3 FFR Guidewire Procedures | 474 |
| 14.4 Market Overview | 488 |
| 14.4.1 By Segment | 489 |
| 14.4.2 By Region | 491 |
| 14.5 Market Analysis and Forecast | 493 |
| 14.5.1 Total Diagnostic Catheter and Guidewire Market | 493 |
| 14.5.2 Interventional Diagnostic Catheter Market | 497 |
| 14.5.3 Interventional Diagnostic Guidewire Market | 501 |
| 14.5.4 FFR Guidewire Market | 505 |
| 14.6 Drivers and Limiters | 509 |
| 14.6.1 Market Drivers | 509 |
| 14.6.2 Market Limiters | 509 |
| 14.7 Competitive Market Share Analysis | 511 |
| Optical Coherence Tomography Catheter Market | 516 |
| 15.1 Executive Summary | 516 |
| 15.1.1 Global Optical Coherence Tomography Catheter Market Overview | 516 |
| 15.1.2 Competitive Analysis | 518 |
| 15.1.3 Procedures Included | 519 |
| 15.1.4 Regions Included | 520 |
| 15.2 Introduction | 522 |
| 15.2.1 OCT Applications | 523 |
| 15.3 Procedure Numbers | 524 |
| 15.4 Market Analysis and Forecast | 538 |
| 15.5 Drivers and Limiters | 542 |
| 15.5.1 Market Drivers | 542 |
| 15.5.2 Market Limiters | 543 |
| 15.6 Competitive Market Share Analysis | 544 |
| Intravascular Ultrasound Catheter Market | 547 |
| 16.1 Executive Summary | 547 |
| 16.1.1 Global Intravascular Ultrasound Catheter Market Overview | 547 |
| 16.1.2 Competitive Analysis | 549 |
| 16.1.3 Procedures Included | 550 |
| 16.1.4 Regions Included | 551 |
| 16.2 Introduction | 553 |
| 16.2.1 Pre-Stenting Applications | 553 |
| 16.2.2 Post-Stenting Applications | 553 |
| 16.3 Procedure Numbers | 554 |
| 16.4 Market Analysis and Forecast | 568 |
| 16.5 Drivers and Limiters | 572 |
| 16.5.1 Market Drivers | 572 |
| 16.5.2 Market Limiters | 573 |
| 16.6 Competitive Market Share Analysis | 574 |
| Abbreviations | 577 |
The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite includes analysis on the following companies currently active in this market:
| Abbott | Kardia |
| Acrostak | Kimal |
| Advanced Vascular Dynamics | Kojima Medical |
| Alvimedica | Kossel Medical |
| AndraTec | Lepu |
| AngioDynamics | MedAlliance |
| Argon Medical | Medinol |
| Asahi Intecc | Medtronic |
| Avinger | Meril Life Sciences |
| B. Braun | Merit Medical |
| Balton Medical | Morris Innovative |
| Barty Medical | Nipro |
| Baylis Medical | Opsens Medical |
| Becton Dickinson | OrbusNeich |
| Biolife | Oscor |
| Biosensors | PediaVascular |
| Biotronik | Philips |
| Bolton Medical | Reflow Medical |
| Boston Scientific | Rontis |
| Cardionovum | SCW Medicath |
| Cardiovascular Systems, Inc. | Semler Technologies |
| Cardiva Medical | Shenzhen MicroApproach Medical Technology |
| CeloNova BioSciences | Shenzhen X-Way Medical Technology |
| Conavi | ShockWave Medical |
| Contego Medical | SMT |
| Cook Medical | Stentys |
| Cordis | Teleflex |
| DISA Medinotec | Terumo |
| Elixir Medical Corporation | Tricol Biomedical |
| Eucatech | KAI Medical |
| Galt Medical | TZ Medical |
| Hexacath | Vascular Perspectives |
| IMDS | Vasorum |
| InnoTherapy | WEGO |
| Innovative Cardiovascular Solutions LLC | Wellinq |
| iVascular | Z-Medica |
The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite Chart List:
| List of Charts | |
| Chart 1‑1: Interventional Cardiology Market by Segment, Global, 2022 – 2029 | 2 |
| Chart 1‑2: Interventional Cardiology Procedures, Global, 2022 & 2029 | 2 |
| Chart 2‑1: Multi-Scenario Interventional Cardiology Market Forecast, Global, 2019 – 2029 (US$M) | 40 |
| Chart 5‑1: Interventional Cardiology Market by Segment, Global, 2019 – 2029 | 125 |
| Chart 5‑2: Interventional Cardiology Market by Region, Global, 2019 – 2029 | 129 |
| Chart 5‑3: Leading Competitors, Interventional Cardiology Market, Global, 2022 | 141 |
| Chart 6‑1: Coronary Stent Market, Global, 2022 & 2029 | 167 |
| Chart 6‑2: Angioplasty/PCI Procedures, Global, 2022 | 167 |
| Chart 6‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 177 |
| Chart 6‑4: Coronary Stent Market by Segment, Global, 2019 – 2022 | 191 |
| Chart 6‑5: Coronary Stent Market by Region, Global, 2019 – 2029 | 193 |
| Chart 6‑6: Leading Competitors, Coronary Stent Market, Global, 2022 | 212 |
| Chart 7‑1: Coronary Balloon Catheter Market, Global, 2022 & 2029 | 215 |
| Chart 7‑2: Angioplasty/PCI Procedures, Global, 2022 | 215 |
| Chart 7‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 225 |
| Chart 7‑4: Coronary Balloon Catheter Market by Segment, Global, 2019 – 2029 | 239 |
| Chart 7‑5: Coronary Balloon Catheter Market by Region, Global, 2019 – 2029 | 241 |
| Chart 7‑6: Leading Competitors, Coronary Balloon Catheter Market, Global, 2022 | 259 |
| Chart 8‑1: Interventional Coronary Catheter Market, Global, 2022 & 2029 | 261 |
| Chart 8‑2: Angioplasty/PCI Procedures, Global, 2022 | 261 |
| Chart 8‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 269 |
| Chart 8‑4: Leading Competitors, Interventional Coronary Catheter Market, Global, 2022 | 290 |
| Chart 9‑1: Interventional Coronary Guidewire Market, Global, 2022 & 2029 | 292 |
| Chart 9‑2: Angioplasty/PCI Procedures, Global, 2022 | 292 |
| Chart 9‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 300 |
| Chart 9‑4: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022 | 321 |
| Chart 10‑1: Coronary Embolic Protection Device Market, Global, 2022 & 2029 | 324 |
| Chart 10‑2: Coronary Embolic Protection Procedures, Global, 2022 | 324 |
| Chart 10‑3: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022 | 338 |
| Chart 11‑1: Atherectomy and IVL Device Market, Global, 2022 & 2029 | 341 |
| Chart 11‑2: Atherectomy and IVL Procedures, Global, 2022 | 341 |
| Chart 11‑3: Coronary Atherectomy and IVL Procedures by Region, Global, 2019 – 2029 | 349 |
| Chart 11‑4: Leading Competitors, Coronary Atherectomy and IVL Device Market, Global, 2022 | 369 |
| Chart 12‑1: Coronary Introducer Sheath Market, Global, 2022 & 2029 | 372 |
| Chart 12‑2: Coronary Introducer Sheath Procedures, Global, 2022 | 372 |
| Chart 12‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 381 |
| Chart 12‑4: Leading Competitors, Coronary Introducer Sheath Market, Global, 2022 | 403 |
| Chart 13‑1: Coronary Vascular Closure Device Market, Global, 2022 & 2029 | 405 |
| Chart 13‑2: Coronary Vascular Closure Device Procedures, Global, 2022 | 405 |
| Chart 13‑3: Catheterization Procedures by Region, Global, 2019 – 2029 | 414 |
| Chart 13‑4: Coronary Vascular Closure Device Market by Segment, Global, 2019 – 2029 | 428 |
| Chart 13‑5: Coronary Vascular Closure Device Market by Region, Global, 2019 – 2029 | 430 |
| Chart 13‑6: Leading Competitors, Coronary Vascular Closure Device Market, Global, 2022 | 449 |
| Chart 14‑1: Diagnostic Catheter and Guidewire Market, Global, 2022 & 2029 | 452 |
| Chart 14‑2: Diagnostic Catheter and Guidewire Procedures, Global, 2022 | 452 |
| Chart 14‑3: Angiography Procedures by Region, Global, 2019 – 2029 | 462 |
| Chart 14‑4: FFR Guidewire Procedures by Region, Global, 2019 – 2029 | 476 |
| Chart 14‑5: Diagnostic Catheter and Guidewire Market by Segment, Global, 2019 – 2029 | 490 |
| Chart 14‑6: Diagnostic Catheter and Guidewire Market by Region, Global, 2019 – 2029 | 492 |
| Chart 14‑7: Leading Competitors, Diagnostic Catheter and Guidewire Market, Global, 2022 | 515 |
| Chart 15‑1: OCT Catheter Market, Global, 2022 & 2029 | 517 |
| Chart 15‑2: OCT Catheter Procedures, Global, 2022 | 517 |
| Chart 15‑3: OCT Procedures by Region, Global, 2019 – 2029 | 526 |
| Chart 15‑4: Leading Competitors, OCT Catheter Market, Global, 2022 | 546 |
| Chart 16‑1: IVUS Catheter Market, Global, 2022 & 2029 | 548 |
| Chart 16‑2: IVUS Catheter Procedures, Global, 2022 | 548 |
| Chart 16‑3: IVUS Procedures by Region, Global, 2019 – 2029 | 556 |
| Chart 16‑4: Leading Competitors, IVUS Catheter Market, Global, 2022 | 576 |
The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite Figure List:
| List of Figures | |
| Figure 1‑1: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (1 of 2) | 4 |
| Figure 1‑2: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (2 of 2) | 4 |
| Figure 1‑3: Companies Researched in This Report (1 of 2) | 5 |
| Figure 1‑4: Companies Researched in This Report (2 of 2) | 6 |
| Figure 1‑5: Factors Impacting the Interventional Cardiology Device Market by Segment, Global (1 of 2) | 7 |
| Figure 1‑6: Factors Impacting the Interventional Cardiology Device Market by Segment, Global (2 of 2) | 8 |
| Figure 1‑7: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (1 of 2) | 9 |
| Figure 1‑8: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (2 of 2) | 10 |
| Figure 1‑9: Interventional Cardiology Device Procedures Covered | 11 |
| Figure 1‑10: Interventional Cardiology Device Markets Covered | 12 |
| Figure 1‑11: Interventional Cardiology Device Market Regions Covered, Global (1 of 2) | 13 |
| Figure 1‑12: Interventional Cardiology Device Market Regions Covered, Global (2 of 2) | 14 |
| Figure 1‑13: Version History | 15 |
| Figure 2‑1: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) | 34 |
| Figure 2‑2: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) | 35 |
| Figure 2‑3: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) | 36 |
| Figure 2‑4: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) | 37 |
| Figure 2‑5: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) | 38 |
| Figure 2‑6: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) | 39 |
| Figure 4‑1: Coronary Stents by Company | 50 |
| Figure 4‑2: Coronary Balloon Catheters by Company | 52 |
| Figure 4‑3: Interventional Coronary Catheters by Company | 54 |
| Figure 4‑4: Interventional Coronary Guidewires by Company | 56 |
| Figure 4‑5: Coronary Embolic Protection Devices by Company | 58 |
| Figure 4‑6: Coronary Atherectomy and Intravascular Lithotripsy Devices by Company | 60 |
| Figure 4‑7: Coronary Introducer Sheaths by Company (1 of 2) | 62 |
| Figure 4‑8: Coronary Introducer Sheaths by Company (2 of 2) | 63 |
| Figure 4‑9: Coronary Vascular Closure Devices by Company | 65 |
| Figure 4‑10: Diagnostic Coronary Catheters & Guidewires by Company | 67 |
| Figure 4‑11: Coronary Intravascular Ultrasound Devices by Company | 69 |
| Figure 4‑12: Coronary Optical Coherence Tomography by Company | 71 |
| Figure 4‑13: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System | 72 |
| Figure 4‑14: Class 2 Device Recall XIENCE Sierra TM RX 3.5mm x 33mm | 72 |
| Figure 4‑15: Class 2 Device Recall Cordis Precise Nitinol Stent System | 72 |
| Figure 4‑16: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System | 73 |
| Figure 4‑17: Class 2 Device Recall Rebel Monorail PtCr Coronary Stent System | 73 |
| Figure 4‑18: Class 1 Device Recall NC TREK Coronary Dilatation Catheter | 74 |
| Figure 4‑19: Class 1 Device Recall NC TRAVLER Coronary Dilatation Catheter | 74 |
| Figure 4‑20: Class 2 Device Recall NC Emerge OverTheWire (OTW) and NC Emerge Monorail (MR) PTCA Dilatation Catheters | 75 |
| Figure 4‑21: Class 2 Device Recall Spectranetics AngioSculpt PTCA Scoring Balloon Catheter | 75 |
| Figure 4‑22: Class 2 Device Recall Solarice Rapid Exchange Balloon Dilatation Catheter | 75 |
| Figure 4‑23: Class 2 Device Recall Euphoria Rapid Exchange Balloon Dilatation Catheter | 75 |
| Figure 4‑24: Class 2 Device Recall MAMBA Flex 135 Microcatheter | 76 |
| Figure 4‑25: Class 2 Device Recall MAMBA Microcatheter | 76 |
| Figure 4‑26: Class 2 Device Recall Guidezilla II Guide Extension Catheter | 76 |
| Figure 4‑27: Class 1 Device Recall SHERPA NX ACTIVE GUIDING CATHETER | 77 |
| Figure 4‑28: Class 3 Device Recall Cordis Vista Brite Tip AdroitTM Guiding Catheter | 77 |
| Figure 4‑29: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters | 77 |
| Figure 4‑30: Class 1 Device Recall 6F Taiga Guiding Catheter | 78 |
| Figure 4‑31: Class 2 Device Recall Destination Guiding Sheath | 78 |
| Figure 4‑32: Class 2 Device Recall Stingray" Guidewire | 79 |
| Figure 4‑33: Class 1 Device Recall TurboHawk Plus | 80 |
| Figure 4‑34: Class 1 Device Recall HawkOne | 80 |
| Figure 4‑35: Class 2 Device Recall Boston Scientific ROTAPRO | 80 |
| Figure 4‑36: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM | 80 |
| Figure 4‑37: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER | 81 |
| Figure 4‑38: Class 2 Device Recall | 81 |
| Figure 4‑39: Class 2 Device Recall Flexor CheckFlo Introducer Raabe Modification | 81 |
| Figure 4‑40: Class 2 Device Recall Prelude Short Sheath Introducer | 82 |
| Figure 4‑41: Class 2 Device Recall Prelude SNAP Splittable Sheath Introducer | 82 |
| Figure 4‑42: Class 2 Device Recall Avanti Catheter Sheath Introducer | 82 |
| Figure 4‑43: Class 1 Device Recall Flexor CheckFlo Introducer | 82 |
| Figure 4‑44: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS | 83 |
| Figure 4‑45: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER | 83 |
| Figure 4‑46: Class 1 Device Recall Portico Solo ReCollapsible Access System | 83 |
| Figure 4‑47: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System | 83 |
| Figure 4‑48: Class 2 Device Recall Microintroducer Kit | 84 |
| Figure 4‑49: Class 2 Device Recall PreludeSYNC DISTAL Radial Compression Devices | 85 |
| Figure 4‑50: Class 2 Device Recall AngioSeal Evolution | 85 |
| Figure 4‑51: Class 1 Device Recall Imager II 5F Angiographic Catheter | 86 |
| Figure 4‑52: Class 1 Device Recall ACIST Kodama Intravascular Ultrasound Catheter | 87 |
| Figure 4‑53: Class 2 Device Recall iLab Polaris MultiModality Guidance System | 87 |
| Figure 4‑54: IonMAN Trial- First In Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (IonMAN) | 89 |
| Figure 4‑55: RESOLUTE ONYX China Single Arm Study | 89 |
| Figure 4‑56: Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48) | 90 |
| Figure 4‑57: Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System | 90 |
| Figure 4‑58: PROMUS PREMIER™ China Post-Approval Study | 91 |
| Figure 4‑59: A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s) | 91 |
| Figure 4‑60: China Resolute Integrity 34/38 mm Study | 92 |
| Figure 4‑61: ILUMIEN IV: OPTIMAL PCI | 92 |
| Figure 4‑62: RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort) | 93 |
| Figure 4‑63: RESOLUTE ONYX Post-Approval Study (ONYX PAS) | 93 |
| Figure 4‑64: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-V) | 94 |
| Figure 4‑65: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48) | 94 |
| Figure 4‑66: Sirolimus DEB in Coronary Bifurcation Lesions | 95 |
| Figure 4‑67: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV) | 95 |
| Figure 4‑68: Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF) | 96 |
| Figure 4‑69: Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis (CREST) | 96 |
| Figure 4‑70: Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater | 97 |
| Figure 4‑71: TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon (TRANSFORM I) | 97 |
| Figure 4‑72: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease | 97 |
| Figure 4‑73: ACOART Paclitaxel SVD: Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases | 98 |
| Figure 4‑74: FIRE AND ICE II Trial Pilot | 99 |
| Figure 4‑75: Outcomes of Interventional Catheterization in Infants Less Than 3 Months With Critical Congenital Heart Disease (CHD) | 99 |
| Figure 4‑76: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation (STOP AF First) | 100 |
| Figure 4‑77: Chronic Total Occlusion Percutaneous Coronary Intervention Study (CTO-PCI) | 101 |
| Figure 4‑78: Pressure Guidewire Comparison | 101 |
| Figure 4‑79: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants (CAPTURE2) | 102 |
| Figure 4‑80: transShield Embolic Protection System Feasibility Study | 102 |
| Figure 4‑81: The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation | 103 |
| Figure 4‑82: Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis | 103 |
| Figure 4‑83: The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s | 104 |
| Figure 4‑84: Coronary Atherectomy System in Patients With Coronary Calcification (CORECT) | 104 |
| Figure 4‑85: Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions (ROTA-CUT) | 105 |
| Figure 4‑86: Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (ELCA-CAD) | 105 |
| Figure 4‑87: VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial | 106 |
| Figure 4‑88: Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation (Style-AF) | 106 |
| Figure 4‑89: Application of Vascular Closure Device in Transvenous Cardiac Intervention | 107 |
| Figure 4‑90: Comparison of Different Vascular Closure Device in TAVI | 107 |
| Figure 4‑91: Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease | 108 |
| Figure 4‑92: Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease (VASCADE) | 108 |
| Figure 4‑93: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial | 109 |
| Figure 4‑94: Vascular Closure Device in Transcatheter Aortic Valve Replacement | 109 |
| Figure 4‑95: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) | 110 |
| Figure 4‑96: Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES) | 110 |
| Figure 4‑97: Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System | 111 |
| Figure 4‑98: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) | 111 |
| Figure 4‑99: The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) (OCTOBER) | 112 |
| Figure 4‑100: Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention (OCTIVUS) | 112 |
| Figure 4‑101: Intravascular Ultrasound Guidance for Complex High-Risk Indicated Procedures (IVUS-CHIP) | 113 |
| Figure 4‑102: The OPTIMAL Randomized Controlled Trial | 113 |
| Figure 4‑103: IVUS VS CAG Guided PCI for Patients With LMB Lesion (Infinite) | 114 |
| Figure 4‑104: Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation (GUIDE DES) | 114 |
| Figure 4‑105: Clinical Evaluation of a New High-speed and High-Resolution Intravascular Ultrasound System (NEW-IVUS) | 115 |
| Figure 4‑106: Optical Coherence Tomography of the Saphenous Vein Graft (OCTOCAB) | 116 |
| Figure 4‑107: Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography | 116 |
| Figure 4‑108: Does OCT Optimise Results of Stenting on the Left Main Stem (DOCTORS-LM) | 117 |
| Figure 4‑109: Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging | 117 |
| Figure 5‑1: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (1 of 2) | 123 |
| Figure 5‑2: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (2 of 2) | 124 |
| Figure 5‑3: Interventional Cardiology Market by Region, Global, 2019 – 2029 (US$M) | 128 |
| Figure 5‑4: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (1 of 2) | 139 |
| Figure 5‑5: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (2 of 2) | 140 |
| Figure 5‑6: SWOT Analysis, Abbott (1 of 2) | 155 |
| Figure 5‑7: SWOT Analysis, Abbott (2 of 2) | 156 |
| Figure 5‑8: SWOT Analysis, Asahi Intecc | 157 |
| Figure 5‑9: SWOT Analysis, Boston Scientific | 158 |
| Figure 5‑10: SWOT Analysis, Cordis | 159 |
| Figure 5‑11: SWOT Analysis, Cook Medical | 160 |
| Figure 5‑12: SWOT Analysis, Medtronic | 161 |
| Figure 5‑13: SWOT Analysis, Penumbra | 162 |
| Figure 5‑14: SWOT Analysis, Philips | 163 |
| Figure 5‑15: SWOT Analysis, Teleflex | 164 |
| Figure 5‑16: SWOT Analysis, Terumo | 165 |
| Figure 6‑1: Coronary Stent Procedures Covered | 169 |
| Figure 6‑2: Coronary Stent Markets Covered | 170 |
| Figure 6‑3: Coronary Stent Regions Covered, Global (1 of 2) | 171 |
| Figure 6‑4: Coronary Stent Regions Covered, Global (2 of 2) | 172 |
| Figure 6‑5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 176 |
| Figure 6‑6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 | 178 |
| Figure 6‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 179 |
| Figure 6‑8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 180 |
| Figure 6‑9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 | 181 |
| Figure 6‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 182 |
| Figure 6‑11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 183 |
| Figure 6‑12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 | 184 |
| Figure 6‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 185 |
| Figure 6‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 186 |
| Figure 6‑15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 187 |
| Figure 6‑16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 | 188 |
| Figure 6‑17: Coronary Stent Market by Segment, Global, 2019 – 2029 (US$M) | 190 |
| Figure 6‑18: Coronary Stent Market by Region, Global, 2019 – 2029 (US$M) | 192 |
| Figure 6‑19: Total Coronary Stent Market, Global, 2019 – 2029 | 194 |
| Figure 6‑20: Units Sold by Region, Coronary Stent Market, Global, 2019 – 2029 | 195 |
| Figure 6‑21: Average Selling Price by Region, Coronary Stent Market, Global, 2019 – 2029 (US$) | 196 |
| Figure 6‑22: Market Value by Region, Coronary Stent Market, Global, 2019 – 2029 (US$M) | 197 |
| Figure 6‑23: Bare-Metal Stent Market, Global, 2019 – 2029 | 198 |
| Figure 6‑24: Units Sold by Region, Bare-Metal Stent Market, Global, 2019 – 2029 | 199 |
| Figure 6‑25: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$) | 200 |
| Figure 6‑26: Market Value by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$M) | 201 |
| Figure 6‑27: Drug-Eluting Stent Market, Global, 2019 – 2029 | 202 |
| Figure 6‑28: Units Sold by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 | 203 |
| Figure 6‑29: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$) | 204 |
| Figure 6‑30: Market Value by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$M) | 205 |
| Figure 6‑31: Leading Competitors, Coronary Stent Market, Global, 2022 | 211 |
| Figure 7‑1: Coronary Balloon Catheter Procedures Covered | 217 |
| Figure 7‑2: Coronary Balloon Catheter Markets Covered | 218 |
| Figure 7‑3: Coronary Balloon Catheter Regions Covered, Global (1 of 2) | 219 |
| Figure 7‑4: Coronary Balloon Catheter Regions Covered, Global (2 of 2) | 220 |
| Figure 7‑5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 224 |
| Figure 7‑6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 | 226 |
| Figure 7‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 227 |
| Figure 7‑8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 228 |
| Figure 7‑9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 | 229 |
| Figure 7‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 230 |
| Figure 7‑11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 231 |
| Figure 7‑12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 | 232 |
| Figure 7‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 233 |
| Figure 7‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 234 |
| Figure 7‑15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 235 |
| Figure 7‑16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 | 236 |
| Figure 7‑17: Coronary Balloon Catheter Market by Segment, Global, 2019 – 2029 (US$M) | 238 |
| Figure 7‑18: Coronary Balloon Catheter Market by Region, Global, 2019 – 2029 (US$M) | 240 |
| Figure 7‑19: Total Coronary Balloon Catheter Market, Global, 2019 – 2029 | 242 |
| Figure 7‑20: Units Sold by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 | 243 |
| Figure 7‑21: Average Selling Price by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 (US$) | 244 |
| Figure 7‑22: Market Value by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 (US$M) | 245 |
| Figure 7‑23: PTCA Balloon Catheter Market, Global, 2019 – 2029 | 246 |
| Figure 7‑24: Units Sold by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 | 247 |
| Figure 7‑25: Average Selling Price by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 (US$) | 248 |
| Figure 7‑26: Market Value by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 (US$M) | 249 |
| Figure 7‑27: Specialty Balloon Catheter Market, Global, 2019 – 2029 | 250 |
| Figure 7‑28: Units Sold by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 | 251 |
| Figure 7‑29: Average Selling Price by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 (US$) | 252 |
| Figure 7‑30: Market Value by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 (US$M) | 253 |
| Figure 7‑31: Leading Competitors, Coronary Balloon Catheter Market, Global, 2022 | 258 |
| Figure 8‑1: Interventional Coronary Catheter Procedures Covered | 263 |
| Figure 8‑2: Interventional Coronary Catheter Regions Covered, Global (1 of 2) | 264 |
| Figure 8‑3: Interventional Coronary Catheter Regions Covered, Global (2 of 2) | 265 |
| Figure 8‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 268 |
| Figure 8‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 | 270 |
| Figure 8‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 271 |
| Figure 8‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 272 |
| Figure 8‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 | 273 |
| Figure 8‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 274 |
| Figure 8‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 275 |
| Figure 8‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 | 276 |
| Figure 8‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 277 |
| Figure 8‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 278 |
| Figure 8‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 279 |
| Figure 8‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 | 280 |
| Figure 8‑16: Interventional Coronary Catheter Market, Global, 2019 – 2029 | 281 |
| Figure 8‑17: Units Sold by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 | 282 |
| Figure 8‑18: Average Selling Price by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 (US$) | 283 |
| Figure 8‑19: Market Value by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 (US$M) | 284 |
| Figure 8‑20: Leading Competitors, Interventional Coronary Catheter Market, Global, 2022 | 289 |
| Figure 9‑1: Interventional Coronary Guidewire Procedures Covered | 294 |
| Figure 9‑2: Interventional Coronary Guidewire Regions Covered, Global (1 of 2) | 295 |
| Figure 9‑3: Interventional Coronary Guidewire Regions Covered, Global (2 of 2) | 296 |
| Figure 9‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 299 |
| Figure 9‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 | 301 |
| Figure 9‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 302 |
| Figure 9‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 303 |
| Figure 9‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 | 304 |
| Figure 9‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 305 |
| Figure 9‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 306 |
| Figure 9‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 | 307 |
| Figure 9‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 308 |
| Figure 9‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 309 |
| Figure 9‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 310 |
| Figure 9‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 | 311 |
| Figure 9‑16: Interventional Coronary Guidewire Market, Global, 2019 – 2029 | 312 |
| Figure 9‑17: Units Sold by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 | 313 |
| Figure 9‑18: Average Selling Price by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 (US$) | 314 |
| Figure 9‑19: Market Value by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 (US$M) | 315 |
| Figure 9‑20: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022 | 320 |
| Figure 10‑1: Coronary Embolic Protection Device Regions Covered, Global (1 of 2) | 326 |
| Figure 10‑2: Coronary Embolic Protection Device Regions Covered, Global (2 of 2) | 327 |
| Figure 10‑3: Coronary Embolic Protection Device Market, Global, 2019 – 2029 | 330 |
| Figure 10‑4: Units Sold by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 | 331 |
| Figure 10‑5: Average Selling Price by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$) | 332 |
| Figure 10‑6: Market Value by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$M) | 333 |
| Figure 10‑7: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022 | 337 |
| Figure 11‑1: Atherectomy and IVL Device Procedures Covered | 343 |
| Figure 11‑2: Atherectomy and IVL Device Regions Covered, Global (1 of 2) | 344 |
| Figure 11‑3: Atherectomy and IVL Device Regions Covered, Global (2 of 2) | 345 |
| Figure 11‑4: Coronary Atherectomy and IVL Procedures by Region, Global, 2019 – 2029 | 348 |
| Figure 11‑5: Coronary Atherectomy and IVL Procedures by Country, North America, 2019 – 2029 | 350 |
| Figure 11‑6: Coronary Atherectomy and IVL Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 351 |
| Figure 11‑7: Coronary Atherectomy and IVL Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 352 |
| Figure 11‑8: Coronary Atherectomy and IVL Procedures by Country, Western Europe, 2019 – 2029 | 353 |
| Figure 11‑9: Coronary Atherectomy and IVL Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 354 |
| Figure 11‑10: Coronary Atherectomy and IVL Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 355 |
| Figure 11‑11: Coronary Atherectomy and IVL Procedures by Country, Middle East, 2019 – 2029 | 356 |
| Figure 11‑12: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 357 |
| Figure 11‑13: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 358 |
| Figure 11‑14: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 359 |
| Figure 11‑15: Coronary Atherectomy and IVL Procedures by Country, Africa, 2019 – 2029 | 360 |
| Figure 11‑16: Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 | 361 |
| Figure 11‑17: Units Sold by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 | 362 |
| Figure 11‑18: Average Selling Price by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 (US$) | 363 |
| Figure 11‑19: Market Value by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 (US$M) | 364 |
| Figure 11‑20: Leading Competitors, Coronary Atherectomy and IVL Device Market, Global, 2022 | 368 |
| Figure 12‑1: Coronary Introducer Sheath Procedures Covered | 374 |
| Figure 12‑2: Coronary Introducer Sheath Regions Covered, Global (1 of 2) | 375 |
| Figure 12‑3: Coronary Introducer Sheath Regions Covered, Global (2 of 2) | 376 |
| Figure 12‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 380 |
| Figure 12‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 | 382 |
| Figure 12‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 383 |
| Figure 12‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 384 |
| Figure 12‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 | 385 |
| Figure 12‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 386 |
| Figure 12‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 387 |
| Figure 12‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 | 388 |
| Figure 12‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 389 |
| Figure 12‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 390 |
| Figure 12‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 391 |
| Figure 12‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 | 392 |
| Figure 12‑16: Coronary Introducer Sheath Market, Global, 2019 – 2029 | 393 |
| Figure 12‑17: Units Sold by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 | 394 |
| Figure 12‑18: Average Selling Price by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 (US$) | 395 |
| Figure 12‑19: Market Value by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 (US$M) | 396 |
| Figure 12‑20: Leading Competitors, Coronary Introducer Sheath Market, Global, 2022 | 402 |
| Figure 13‑1: Coronary Vascular Closure Device Procedures Covered | 407 |
| Figure 13‑2: Coronary Vascular Closure Device Markets Covered | 408 |
| Figure 13‑3: Coronary Vascular Closure Device Regions Covered, Global (1 of 2) | 409 |
| Figure 13‑4: Coronary Vascular Closure Device Regions Covered, Global (2 of 2) | 410 |
| Figure 13‑5: Total Catheterization Procedures by Region, Global, 2019 – 2029 | 413 |
| Figure 13‑6: Catheterization Procedures by Country, North America, 2019 – 2029 | 415 |
| Figure 13‑7: Catheterization Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 416 |
| Figure 13‑8: Catheterization Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 417 |
| Figure 13‑9: Catheterization Procedures by Country, Western Europe, 2019 – 2029 | 418 |
| Figure 13‑10: Catheterization Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 419 |
| Figure 13‑11: Catheterization Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 420 |
| Figure 13‑12: Catheterization Procedures by Country, Middle East, 2019 – 2029 | 421 |
| Figure 13‑13: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 422 |
| Figure 13‑14: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 423 |
| Figure 13‑15: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 424 |
| Figure 13‑16: Catheterization Procedures by Country, Africa, 2019 – 2029 | 425 |
| Figure 13‑17: Coronary Vascular Closure Device Market by Segment, Global, 2019 – 2029 (US$M) | 427 |
| Figure 13‑18: Coronary Vascular Closure Device Market by Region, Global, 2019 – 2029 (US$M) | 429 |
| Figure 13‑19: Coronary Vascular Closure Device Market, Global, 2019 – 2029 | 432 |
| Figure 13‑20: Units Sold by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 | 433 |
| Figure 13‑21: Average Selling Price by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 (US$) | 434 |
| Figure 13‑22: Market Value by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 (US$M) | 435 |
| Figure 13‑23: Invasive VCD Market, Global, 2019 – 2029 | 436 |
| Figure 13‑24: Units Sold by Region, Invasive VCD Market, Global, 2019 – 2029 | 437 |
| Figure 13‑25: Average Selling Price by Region, Invasive VCD Market, Global, 2019 – 2029 (US$) | 438 |
| Figure 13‑26: Market Value by Region, Invasive VCD Market, Global, 2019 – 2029 (US$M) | 439 |
| Figure 13‑27: Non-Invasive VCD Market, Global, 2019 – 2029 | 440 |
| Figure 13‑28: Units Sold by Region, Non-Invasive VCD Market, Global, 2019 – 2029 | 441 |
| Figure 13‑29: Average Selling Price by Region, Non-Invasive VCD Market, Global, 2019 – 2029 (US$) | 442 |
| Figure 13‑30: Market Value by Region, Non-Invasive VCD Market, Global, 2019 – 2029 (US$M) | 443 |
| Figure 13‑31: Leading Competitors, Coronary Vascular Closure Device Market, Global, 2022 | 448 |
| Figure 14‑1: Diagnostic Catheter and Guidewire Procedures Covered | 454 |
| Figure 14‑2: Diagnostic Catheter and Guidewire Markets Covered | 455 |
| Figure 14‑3: Diagnostic Catheter and Guidewire Regions Covered, Global (1 of 2) | 456 |
| Figure 14‑4: Diagnostic Catheter and Guidewire Regions Covered, Global (2 of 2) | 457 |
| Figure 14‑5: Total Diagnostic Catheter and Guidewire Procedures by Segment, Global, 2019 – 2029 | 459 |
| Figure 14‑6: Angiography Procedures by Region, Global, 2019 – 2029 | 461 |
| Figure 14‑7: Angiography Procedures by Country, North America, 2019 – 2029 | 463 |
| Figure 14‑8: Angiography Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 464 |
| Figure 14‑9: Angiography Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 465 |
| Figure 14‑10: Angiography Procedures by Country, Western Europe, 2019 – 2029 | 466 |
| Figure 14‑11: Angiography Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 467 |
| Figure 14‑12: Angiography Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 468 |
| Figure 14‑13: Angiography Procedures by Country, Middle East, 2019 – 2029 | 469 |
| Figure 14‑14: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 470 |
| Figure 14‑15: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 471 |
| Figure 14‑16: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 472 |
| Figure 14‑17: Angiography Procedures by Country, Africa, 2019 – 2029 | 473 |
| Figure 14‑18: FFR Guidewire Procedures by Region, Global, 2019 – 2029 | 475 |
| Figure 14‑19: FFR Guidewire Procedures by Country, North America, 2019 – 2029 | 477 |
| Figure 14‑20: FFR Guidewire Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 478 |
| Figure 14‑21: FFR Guidewire Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 479 |
| Figure 14‑22: FFR Guidewire Procedures by Country, Western Europe, 2019 – 2029 | 480 |
| Figure 14‑23: FFR Guidewire Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 481 |
| Figure 14‑24: FFR Guidewire Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 482 |
| Figure 14‑25: FFR Guidewire Procedures by Country, Middle East, 2019 – 2029 | 483 |
| Figure 14‑26: FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 484 |
| Figure 14‑27 FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 485 |
| Figure 14‑28: FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 486 |
| Figure 14‑29: FFR Guidewire Procedures by Country, Africa, 2019 – 2029 | 487 |
| Figure 14‑30: Diagnostic Catheter and Guidewire Market by Segment, Global, 2019 – 2029 (US$M) | 489 |
| Figure 14‑31: Diagnostic Catheter and Guidewire Market by Region, Global, 2019 – 2029 (US$M) | 491 |
| Figure 14‑32: Total Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 | 493 |
| Figure 14‑33: Units Sold by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 | 494 |
| Figure 14‑34: Average Selling Price by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 (US$) | 495 |
| Figure 14‑35: Market Value by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 (US$M) | 496 |
| Figure 14‑36: Interventional Diagnostic Catheter Market, Global, 2019 – 2029 | 497 |
| Figure 14‑37: Units Sold by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 | 498 |
| Figure 14‑38: Average Selling Price by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 (US$) | 499 |
| Figure 14‑39: Market Value by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 (US$M) | 500 |
| Figure 14‑40: Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 | 501 |
| Figure 14‑41: Units Sold by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 | 502 |
| Figure 14‑42: Average Selling Price by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 (US$) | 503 |
| Figure 14‑43: Market Value by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 (US$M) | 504 |
| Figure 14‑44: FFR Guidewire Market, Global, 2019 – 2029 | 505 |
| Figure 14‑45: Units Sold by Region, FFR Guidewire Market, Global, 2019 – 2029 | 506 |
| Figure 14‑46: Average Selling Price by Region, FFR Guidewire Market, Global, 2019 – 2029 (US$) | 507 |
| Figure 14‑47: Market Value by Region, FFR Guidewire Market, Global, 2019 – 2029 (US$M) | 508 |
| Figure 14‑48: Leading Competitors, Diagnostic Catheter and Guidewire Market, Global, 2022 | 514 |
| Figure 15‑1: OCT Catheter Procedures Covered | 519 |
| Figure 15‑2: OCT Catheter Regions Covered, Global (1 of 2) | 520 |
| Figure 15‑3: OCT Catheter Regions Covered, Global (2 of 2) | 521 |
| Figure 15‑4: OCT Procedures by Region, Global, 2019 – 2029 | 525 |
| Figure 15‑5: OCT Procedures by Country, North America, 2019 – 2029 | 527 |
| Figure 15‑6: OCT Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 528 |
| Figure 15‑7: OCT Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 529 |
| Figure 15‑8: OCT Procedures by Country, Western Europe, 2019 – 2029 | 530 |
| Figure 15‑9: OCT Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 531 |
| Figure 15‑10: OCT Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 532 |
| Figure 15‑11: OCT Procedures by Country, Middle East, 2019 – 2029 | 533 |
| Figure 15‑12: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 534 |
| Figure 15‑13: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 535 |
| Figure 15‑14: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 536 |
| Figure 15‑15: OCT Procedures by Country, Africa, 2019 – 2029 | 537 |
| Figure 15‑16: OCT Catheter Market, Global, 2019 – 2029 | 538 |
| Figure 15‑17: Units Sold by Region, OCT Catheter Market, Global, 2019 – 2029 | 539 |
| Figure 15‑18: Average Selling Price by Region, OCT Catheter Market, Global, 2019 – 2029 (US$) | 540 |
| Figure 15‑19: Market Value by Region, OCT Catheter Market, Global, 2019 – 2029 (US$M) | 541 |
| Figure 15‑20: Leading Competitors, OCT Catheter Market, Global, 2022 | 545 |
| Figure 16‑1: IVUS Catheter Procedures Covered | 550 |
| Figure 16‑2: IVUS Catheter Regions Covered, Global (1 of 2) | 551 |
| Figure 16‑3: IVUS Catheter Regions Covered, Global (2 of 2) | 552 |
| Figure 16‑4: IVUS Procedures by Region, Global, 2019 – 2029 | 555 |
| Figure 16‑5: IVUS Procedures by Country, North America, 2019 – 2029 | 557 |
| Figure 16‑6: IVUS Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 558 |
| Figure 16‑7: IVUS Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 559 |
| Figure 16‑8: IVUS Procedures by Country, Western Europe, 2019 – 2029 | 560 |
| Figure 16‑9: IVUS Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 561 |
| Figure 16‑10: IVUS Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 562 |
| Figure 16‑11: IVUS Procedures by Country, Middle East, 2019 – 2029 | 563 |
| Figure 16‑12: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 564 |
| Figure 16‑13: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 565 |
| Figure 16‑14: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 566 |
| Figure 16‑15: IVUS Procedures by Country, Africa, 2019 – 2029 | 567 |
| Figure 16‑16: IVUS Catheter Market, Global, 2019 – 2029 | 568 |
| Figure 16‑17: Units Sold by Region, IVUS Catheter Market, Global, 2019 – 2029 | 569 |
| Figure 16‑18: Average Selling Price by Region, IVUS Catheter Market, Global, 2019 – 2029 (US$) | 570 |
| Figure 16‑19: Market Value by Region, IVUS Catheter Market, Global, 2019 – 2029 (US$M) | 571 |
| Figure 16‑20: Leading Competitors, IVUS Catheter Market, Global, 2022 | 575 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Interventional Cardiology Market Size, Share & COVID19 Impact Analysis | Global | 2023-2029 | MedSuite | Includes: Coronary Stent Market, Coronary Balloon Catheter Market and 10 more
$9,995 – $13,995
iData’s global interventional cardiology MedSuite covers 11 markets including the coronary stent and introducer sheath markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.
- 2023
- 10 Years
- Global
- 577
- MedSuite
Related Reports
